Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Case Series of Ceftaroline-treated Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline, Compared to Vancomycin-treated Patients

NCT01724671 is registered in ClinicalTrials.gov with CPL Associates as lead sponsor.

NCT NCT01724671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01724671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Case Series of Ceftaroline-treated Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline, Compared to Vancomycin-treated Patients
Lead sponsor
CPL Associates
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2012
Completion date
December 31, 2013
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

absssi, bacteremia, mrsa infection, pneumonia